Ms. Hagen is currently the Interim Chief Executive Officer of Ziopharm. She has served on the Board of Ziopharm since June 2019 and the Board of Vericel since 2013.
She is a 30-year veteran of the biotechnology industry, the last 20 in cell and gene therapy. Ms. Hagen is co-founder of Vineti, a cloud-based software platform company that address...
Roles at Lykan Bioscience